Individuals who may benefit from Ozempic include: 1
Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a promising new type 2 diabetes and weight management treatment
Another study found that people taking Wegovy lost a similar amount of weight over a 68-week period, results that surpass any previous obesity drugs
[5] [6] Treatment has been shown to result in "catch-up growth," where the affected testicle increases in volume and recovers size relative to the healthy testicle
Wegovy is more expensive than Ozempic, even on a mg per mg basis
However, the contribution of GLP-1 to insulin stimulation was likely modest, and further evaluation using a GLP-1 receptor antagonist would be necessary